REQUIP

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug REQUIP contains one active pharmaceutical ingredient (API):

1	Ropinirole UNII D7ZD41RZI9 - ROPINIROLE HYDROCHLORIDE
	Ropinirole is a non-ergoline D2/D3 dopamine agonist which stimulates striatal dopamine receptors. Ropinirole alleviates the dopamine deficiency which characterises Parkinson’s disease by stimulating striatal dopamine receptors.
	Read more about Ropinirole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BC04	Ropinirole	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00815759, 00815771, 01413460, 01413483, 01413514, 01413520, 01995746, 01995752, 01995781, 02217548, 02217583, 03123186, 03193749, 03269576, 03440768, 03644755, 03653837, 04078329, 04078335, 04651987, 04652099, 04652107, 05356291, 05356316, 05356322, 05392536, 05396681, 05500351, 05500411, 05501681, 05501698, 05501706, 06829432, 06829449, 06838520, 06838537, 07104091, 07104139, 07104168, 07703905, 07708506, 07708593, 07708618, 07708630, 07721949, 08474565, 08875548, 08875583, 08875608, 09001745, 09001751, 09001768, 09154360, 09154377, 11711187, 13816022, 13816039, 14178380, 14178397, 14274103, 15568433, 16134139
EE	Ravimiamet	1225741, 1225752, 1225763, 1225796, 1225808, 1225819, 1225820, 1811113
ES	Centro de información online de medicamentos de la AEMPS	61464, 61465, 61466, 61468, 61469, 69700, 69701, 69702
FI	Lääkealan turvallisuus- ja kehittämiskeskus	037287, 037305, 037323
FR	Base de données publique des médicaments	61497951, 61553841, 62494787, 66649523, 66695638, 67548121, 68209070, 69016925
GB	Medicines & Healthcare Products Regulatory Agency	136282, 136285, 136288, 146236, 175918, 175920, 175922, 184955, 186099, 186101, 186103, 19180, 19183, 19184, 288792, 368728, 373488, 373491, 38883, 38885, 38904, 38907
HK	Department of Health Drug Office	42369, 57964, 57965, 57966, 61418, 61419
HR	Agencija za lijekove i medicinske proizvode	HR-H-575488109, HR-H-723056317, HR-H-864556067
IE	Health Products Regulatory Authority	13180, 13183, 52761, 79055, 79063, 79079, 79086, 79111, 79128, 79150, 79186, 79192, 79193, 79194, 79195
IL	מִשְׂרַד הַבְּרִיאוּת	6354, 6355, 6356
IT	Agenzia del Farmaco	032261063, 032261101, 032261125, 032261149, 032261164, 032261190, 032261240, 032261265
JP	医薬品医療機器総合機構	1169013F1027, 1169013F2023, 1169013F3020, 1169013G1022, 1169013G2029
LT	Valstybinė vaistų kontrolės tarnyba	1004053, 1004054, 1004056, 1004865, 1004866, 1004867, 1016625, 1016626, 1016627, 1016628, 1016629, 1016630, 1016631, 1016632, 1016633, 1016634, 1016635, 1016636, 1031940, 1031941, 1031943, 1031944, 1050888
MT	Medicines Authority	MA192/00101, MA192/00103, MA192/00104, MA192/00105, MA192/00106, MA192/00108, MA192/00109
NL	Z-Index G-Standaard, PRK	48143, 48151, 48178, 48186, 85626, 85634, 85642
PL	Rejestru Produktów Leczniczych	100130969, 100130975, 100131070, 100193007, 100193020, 100193160, 100193177, 100193190
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65198001, W65198002, W65198003, W65198004, W65198005, W65198006, W65198007, W65198008, W65199001, W65199002, W65199003, W65199004, W65200001, W65200002, W65200003, W65200004
SG	Health Sciences Authority	10975P, 10976P, 11018P, 13763P, 13764P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522030231, 8699522030255, 8699522030262
US	FDA, National Drug Code	0007-4882, 0007-4883
ZA	Health Products Regulatory Authority	41/5.4.1/0604, 41/5.4.1/0606, 41/5.4.1/0607